| Literature DB >> 23553052 |
Thien-Phong Vu Manh1, Yannick Alexandre, Thomas Baranek, Karine Crozat, Marc Dalod.
Abstract
DCs express receptors sensing microbial, danger or cytokine signals, which when triggered in combination drive DC maturation and functional polarization. Maturation was proposed to result from a discrete number of modifications in conventional DCs (cDCs), in contrast to a cell-fate conversion in plasmacytoid DCs (pDCs). cDC maturation is generally assessed by measuring cytokine production and membrane expression of MHC class II and co-stimulation molecules. pDC maturation complexity was demonstrated by functional genomics. Here, pDCs and cDCs were shown to undergo profound and convergent changes in their gene expression programs in vivo during viral infection. This observation was generalized to other stimulation conditions and DC subsets, by public microarray data analyses, PCR confirmation of selected gene expression profiles, and gene regulatory sequence bioinformatics analyses. Thus, maturation is a complex process similarly reshaping all DC subsets, including through the induction of a core set of NF-κB- or IFN-stimulated genes irrespective of stimuli.Entities:
Keywords: Dendritic cell subsets; Gene expression profiling; Human; Maturation; Mouse
Mesh:
Year: 2013 PMID: 23553052 PMCID: PMC3799015 DOI: 10.1002/eji.201243106
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532
Figure 1MCMV infection leads to a profound and convergent genetic reprogramming of all splenic DC subsets in vivo. Genome-wide expression analysis was performed on quiescent (q) versus activated (a) immune cells isolated from the spleen of untreated versus d1.5 MCMV-infected C57BL/6 mice. (A) Unsupervised hierarchical clustering of splenocyte subsets from control or MCMV-infected animals was performed. Unsupervised hierarchical clustering with complete linkage was performed on the 28 707 ProbeSets selected as having at least one Log2 expression value >5 in the dataset and a fold change >2 across all conditions. Boxes highlight clusters of q_DC subsets (gray) versus a_DC subsets (black). (B) Principal component analysis on all ProbeSets present on the microarrays. (C) DC subsets maintain their identity after activation. GSEA was performed using previously published sets of genes corresponding to the transcriptional fingerprints of q_DC subsets as compared with many other leukocytes 4 or corresponding to the genes up or downregulated in the pDC of E2–2 knock-out mice 32. Pair-wise comparisons were performed to assess enrichment of the GeneSets between q_DC subsets as a control, a_DC subsets isolated from d1.5 MCMV-infected mice, and q_DC subsets and their a_DC subset counterparts. Results are represented as circular symbols, the size and intensity of color increasing as the enrichment was stronger and more significant, in a color matching that of the cell subset in which the GeneSet was enriched. Specifically, the circle surface area is proportional to the absolute value of the normalized enrichment score, which varies between ∼1 (no enrichment) and ∼5 (best enrichment possible). The color intensity of circles is indicative of the false-discovery rate statistical q value. Data shown are from two independent replicates from two different experiments except for q_B cells where triplicates were performed and a_B cells where only a singlet experiment was performed.
Figure 2Hundreds of genes are similarly modulated in a_DC subsets as compared with their q_DC subset counterparts. (A and B) The Venn diagrams represent the number of ProbeSets significantly (A) upregulated or (B) downregulated >twofold in a_DC subsets from MCMV-infected mice as compared with their q_DC subset counterparts. (C and D) The heatmaps represent selected functions and pathways found enriched by Ingenuity Pathway Analysis for the sets of genes depicted in the Venn diagrams. The color scale indicates the significance of the enrichment, from white (not enriched) to red (enriched). The data analyzed are the same as in Figure 1.
Figure 3Confirmation of the expression profiles of selected genes by PCR array. The expression pattern of 40 genes upregulated and eight genes downregulated in all splenic DC subsets during MCMV infection as assessed by microarrays was confirmed on independent samples by PCR-array and extended to five other conditions combining different DC subsets (CD8α+ cDCs, pDCs, and GM-CSF bone marrow-derived DCs) and different stimuli (in vivo injection of polyIC, in vivo injection of STAg, in vitro stimulation with polyIC or LPS). The data are shown as a heatmap representing the Log2 fold change in the expression of each gene in stimulated as compared with unstimulated DCs. Values > = 1 are shown in yellow and values < = −1 in blue. For each activation condition, data shown are from two independent replicates from two different experiments.
Microarray data used
| GEO ID | Cell types | Organism | Stimuli | Time points |
|---|---|---|---|---|
| GSE21491 | CD8α+ cDCs, CD11b+ cDCs, pDCs, NK cells, B cells | MCMV v70 K181 | 36 h | |
| GSE45365 | CD8α+ cDCs, CD11b+ cDCs, NK cells, CD8+ T cells, B cells | MCMV v70 K181 | 36 h | |
| GSE39556 | CD8α+ cDCs | Poly(I:C) | 6 h | |
| GSE15907 | CD103+CD11b− DCs | Poly(I:C) | Not available | |
| GSE7831 | pDCs | CpG 1826; influenza PR8 | 4 h | |
| GSE17721 | BMDCs | CpG; LPS; Pam; Poly(I:C); Grd | 4 h | |
| GSE10147 | pDCs | IL3+CpG | 18 h | |
| GSE14000 | MoDCs | LPS | 4 h | |
| GSE14816 | MoDCs | HCMV TB40E | Not available | |
| GSE2706 | MoDCs | LPS; R848; LPS+R848 | 8 h |
Dataset record number in the Gene Expression omnibus (GEO) database.
Immune cell types studied. MoDCs: human monocyte-derived DCs, derived in vitro in GM-CSF and IL-4; BMDCs: mouse DCs derived in vitro in GM-CSF bone marrow cultures.
Source organism for the DCs, human (Homo sapiens) or mouse (Mus musculus).
Stimuli used to mature the DCs.
Duration of the stimulation before cell harvest for microarray analysis.
In-house data.
Figure 4Bioinformatics analysis unraveling a core gene expression program associated with DC maturation conserved between mouse and human irrespective of the microbial stimuli and of the DC subsets studied. GSEA for the Genesets modulated in DC subsets during MCMV infection applied to various public microarray datasets. GeneSets correspond to the different areas of the Venn diagrams in Figure 2. Pair-wise comparisons were performed to assess enrichment of these GeneSets between stimulated versus control cell cultures. The legend is the same as for Figure 1C. The GEO datasets used are listed in Table 1. For each condition, data are shown from pooled replicates of at least two independent experiments.
List of the genes commonly regulated across DC subsets, stimuli, mouse, and human
| Differential expression frequency | Change upon DC maturation | ||
|---|---|---|---|
| Human | Mouse | UP | DOWN |
| 6/6 | 12/12 | CCL2, CCL4, CFLAR, CXCL10, GADD45B, GCH1, MARCKSL1, RGS1, RIPK2 | CERK, IL16, LYL1, MAPK14, MAST3, MXD4, RAMP1, RCBTB2, TOP2B |
| 6/6 | 11/12 | CD38, GPD2, IFI44, IFIH1, IFIT2, IFIT3, IL15RA, ISG20, MX1, OASL, PML, RSAD2, SERPINB9, TDRD7 | CAT, EXOSC5, FES, IFNGR1, INPP5D, LAT2, MICAL1, MYCL1, TK2, CRTAP, CRYL1, FUCA1, TM6SF1 |
| 6/6 | 10/12 | CD80, CXCL9, IRF1, OAS2, RTP4, SOS1, STAT1, TAP1, TNFSF10 | – |
| 5/6 | 12/12 | CD200, CD86, CLIC4, DNAJA2, IL6, PELI1, REL, SDC4, TANK, TLK2, TMCC3, TNFAIP3, TNFSF9, TRAF1 | GLTP, GRK6, HAGH, HMHA1, PDLIM2, PPM1M, PRKDC, RGS18, SFXN3, VPS26B |
| 5/6 | 11/12 | AZI2, B3GNT2, DUSP2, EIF2AK2, GBP2, IL15, IL2RA, NFKBIA, NT5C3, PARP9, PI4K2B, PLA1A, RBBP8, STAT2, TRIM21, UBE2L6, XRN1 | ADD3, ARHGAP18, BNIP3L, CYB5R1, HACL1, MFNG, PNPO, SCARB1, ST6GAL1, XPC, ZMAT3 |
| 5/6 | 10/12 | CCDC50, CFB, JDP2, LTA, NCK2, NMI, PTGS2, TNFSF4, ZNF281 | APEX1, DHRS1, GLUD1, HEXA, HEXB, IDH1, IMPA2, MPHOSPH9, NCOR2, RFNG, RGL2, SMPD2, TRIT1, WDR81, XPOT |
Number of experimental conditions where the genes are found to be significantly modulated in mature DCs as compared to immature DCs/total number of experimental conditions tested.
TFBS enrichment in the core gene sets modulated upon DC maturation
| Expression | Matrix | TF | |
|---|---|---|---|
| UP | IRF_Q6 | Irf1; Irf10 | <10−6 |
| UP | IRF7_01 | Irf7a | <10−6 |
| UP | NFKB_C; NFKAPPAB65_01 | ||
| NFKAPPAB_01; NFKB_Q6 | NFkB | <10−6 | |
| UP | CREL_01 | C-rel | <10−6 |
| UP | ISRE_01 | Isgf3 | 7 × 10−6 |
| UP | ICSBP_Q6 | Irf8 | 9 × 10−6 |
| UP | NFKB_Q6_01 | NFkB | 1.3 × 10−5 |
| UP | IRF1_01; IRF_Q6_01 | Irf1; Irf10 | <4.7 × 10−5 |
| UP | IRF2_01 | Irf2 | 4.7 × 10−5 |
| DOWN | USF2_Q6 | Usf2a | 4 × 10−6 |
| DOWN | USF_C | Usf1 | 9 × 10−6 |
| DOWN | NMYC_01 | N-myc | 2 × 10−5 |
| DOWN | MYC_Q2 | Myc | 4.4 × 10−5 |
Expression pattern. UP: induced in a_DCs as compared with q_DCs; DOWN: repressed in a_DCs as compared with q_DCs.
Name of the TFBS matrix as defined in TRANSFAC.
Transcription factor that could bind to the matrix.
p-Value resulting from the statistical assessment of the enrichment of the matrix in the set of test sequences as compared to the set of control sequences as calculated by using PAASTA (http://trap.molgen.mpg.de/PASTAA.htm).